Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Aldeyra Therapeutics, Inc.

NASDAQ: ALDX · Life Sciences · 4 alerts · CIK 1341235

Share price
$0.6696Close, Nov 16
Market cap
$40.4M
Shares outstanding
60.36MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Aldeyra Therapeutics, Inc. filings on SEC EDGAR ↗

4:02 PM ET 8-K
Business Update

Aldeyra Therapeutics Business Update

Aldeyra Therapeutics has requested that the FDA transfer the review jurisdiction of its ADX-2191 IND for primary vitreoretinal lymphoma from the Division of Ophthalmology to the Division of Hematologic Malignancies 2. In connection with this request, the company has withdrawn its previously agreed-upon Special Protocol Assessment (SPA) protocol, creating uncertainty and potential delays in the clinical development timeline for the candidate.

Counterparty
FDA

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.